The effect of food components on the absorption of P-gp substrates: A review

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 2, 2003, Pages 153-162

  Deferme, Sven ^a   Augustijns, Patrick ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN A; CYTOCHROME P450 INHIBITOR; DEXTROMETHORPHAN; DIAZEPAM; DIGOXIN; DOXORUBICIN; ETOPOSIDE; FELODIPINE; FEXOFENADINE; FLAVONOID; GLUCOSE; GLYCOPROTEIN P; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; KETOCONAZOLE; LOSARTAN; MANNITOL; NIFEDIPINE; PACLITAXEL; PEPPERMINT; PEPPERMINT OIL; RITONAVIR; ROSMARINUS OFFICINALIS EXTRACT; SAQUINAVIR; TALINOLOL; UNINDEXED DRUG; VERAPAMIL; VINBLASTINE; VINCRISTINE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DIETARY INTAKE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG METABOLISM; DRUG PENETRATION; DRUG POTENTIATION; DYSPEPSIA; ENZYME ACTIVITY; ENZYME INHIBITION; FAT INTAKE; FOOD COMPOSITION; FOOD DRUG INTERACTION; GARLIC; GRAPEFRUIT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERICUM PERFORATUM; IRRITABLE COLON; MEAT; METABOLISM; NAUSEA; NONHUMAN; ORANGE JUICE; PEPPER; PERMEABILITY BARRIER; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVIEW; ROSEMARY; STANDARDIZATION; STOMACH MUCOSA; VOMITING;

FLAVONOIDS; FOOD; HUMANS; INTESTINAL ABSORPTION; P-GLYCOPROTEINS; PHARMACOKINETICS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037332007     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235702603     Document Type: Review

References (66)

1. Ambudkar, S. V., Dey, S., Hrycyna, M. R., Pastan, I., Gottesman, M. M. (1999) Biochemical, cellular and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39: 361-398
2. Ameer, B., Weintraub, R. A. (1997) Drug interactions with grapefruit juice. Clin. Pharmacokinet. 33: 103-121
3. Becquemont, L., Verstuyft, C., Kerb, R., Brinkmann, U., Lebot, M., Jaillon, P., Funck-Brentano, C. (2001) Effect of grapefruit juice on digoxin pharmacokinetics in humans. Clin. Pharmacol. Ther. 70: 311-316
4. Beesley, A., Hardcastle, J., Hardcastle, P. T., Taylor, C. J. (1996) Influence of peppermint oil on absorptive and secretory processes in rat small intestine. Gut 39: 214-219
5. Bhardwaj, R. K., Glaeser, H., Becquemont, L., Klotz, U., Gupta, S. K., Fromm, M. F. (2002) Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J. Pharmacol. Exp. Ther. 302: 645-650
6. Bracke, M. E., Depypere, H. T., Boterberg, T., Van Marck, V. L., Vennekens, K. M., Vanluchene, E., Nuytinck, M., Serreyn, R., Mareel, M. M. (1999) Influence of tangeretin on tamoxifen's therapeutic benefit in mammary cancer. J. Natl Cancer Inst. 91: 354-359
7. Breidenbach, T., Kliem, V., Burg, M., Radermacher, J., Hoffmann, M. W., Klempnauer, J. (2000) Profound drop of ciclosporin A whole blood trough levels caused by St. John's wort (Hypericum perforatum). Transplantation 69: 2229-2230
8. Castro, A. F., Altenberg, G. A. (1997) Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem. Pharmacol. 53: 89-93
9. Critchfield, J. W., Welsh, C. J., Phang, J. M., Yeh, G. C. (1994) Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-gp as a putative mechanism. Biochem. Pharmacol. 48: 1437-1445
10. Deferme, S., Van Gelder, J., Augustijns, P. (2002a) Inhibitory effect of fruit extracts on P-glycoprotein-related efflux carriers: An in vitro screening. J. Pharm. Pharmacol. 54: 1213-1219
11. Deferme, S., Mols, R., Van Driessche, W., Augustijns, P. (2002b) Apricot extract inhibits the P-gp mediated efflux of talinolol. J. Pharm. Sci. 91: 2539-2548
12. De Vincenzo, R., Ferlini, C., Distefano, M., Gaggini, C., Riva, A., Bombardelli, E., Morazzoni, P., Valenti, P., Belluti, F., Ranelletti, F. O., Mancuso, S., Scambia, G. (2000) In vitro evaluation of newly developed chalcone analogues in human cancer cells. Cancer Chemother. Pharmacol. 46: 305-312
13. Di Marco, M. P., Edwards, D. J., Wainer, I. W., Ducharme, M. P. (2002) The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextrometorphan: The role of gut CYP3A4 and P-glycoprotein. Life Sci. 71: 1149-1160
14. Di Pietro, A., Conseil, G., Pérez-Victoria, J. M., Dayan, G., Baubichon-Cortay, H., Trompier, D., Steinfels, E., Jault, J.-M., De Wet, H., Maitrejean, M., Comte, G., Boumendjel, A., Mariotte, A.-M., Dumontet, C., McIntosh, D. B., Goffeau, A., Castanys, S., Gamarro, F., Barron, D. (2002) Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell. Mol. Life Sci. 59: 307-322
15. Durr, D., Stieger, B., Kullak-Ublick, G. A., Rentsch, K. M., Steinert, H. C., Meier, P. J., Fattinger, K. (2000) St. John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin. Pharmacol. Ther. 68: 598-604
16. Eagling, V. A., Profit, L., Back, D. J. (1999) Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. Br. J. Clin. Pharmacol. 48: 543-552
17. Edwards, D. J., Fitzsimmons, M. E., Schuetz, E., Yasuda, K., Ducharme, M. P., Warbasse, L. H., Woster, P. M., Schuetz, J. D., Watkins, P. (1999) 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporin disposition, enterocyte CYP3A4, and P-glycopotein. Clin. Pharmacol. Ther. 65: 237-244
18. Evans, A. M. (2000) Influence of dietary components on the gastrointestinal metabolism and transport of drugs. Ther. Drug Monitor. 22: 131-136
19. Fleisher, D., Cheng, L., Zhou, Y., Pao, L.-H., Karim, A. (1999) Drug, meal and formulation interactions influencing drug absorption after oral administration. Clin. Pharmacokinet. 36: 233-254
20. Fontana, R. J., Lown, K. S., Paine, M. F., Fortlage, L., Santella, R. M., Felton, J. S., Knize, M. G., Greenberg, A., Watkins, P. B. (1999) Effects of a chargrilled meat diet on expression of CYP3A4, CYP1A and P-glycoprotein levels in healthy volunteers. Gastroenterology 117: 89-98
21. Foster, B. C., Foster, M. S., Vandenhoek, S., Krantis, A., Budzinski, J. W., Arnason, J. T., Gallicano, K. D., Choudri, S. (2001) An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J. Pharm. Sci. 4: 176-184
22. Fromm, M. F. (2000) P-glycoprotein: A defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int. J. Clin. Pharmacol. Ther. 38: 69-74
23. Guo, L. Q., Taniguchi, M., Chen, Q. Y., Baba, K., Yamazoe, Y. (2001) Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: Properties of umbelliferous or citrus crude extracts and their relative prescriptions. Jpn. J. Pharmacol. 85: 399-408
24. Higgins, C. F. (1992) ABC transporters: From microorganisms to man. Annu. Rev. Cell. Biol. 8: 736-749
25. Hou, Y. C., Hsiu, S. L., Tsao, C. W., Wang, Y. H., Chao, P. D. (2000) Acute intoxication of cyclosporin caused by coadministration of decoctions of the fruits of Citrus Aurantium and the pericarps of Citrus Grandis. Planta Med. 66: 653-655
26. Ikegawa, T., Ushigome, F., Kyoabu, N., Morimoto, S., Shoyama, Y., Naito, M., Tsuruo, T., Ohtani, H., Sawada, Y. (2000) Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Lett. 160: 21-28
27. Ioannides, C. (2002) Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32: 451-478
28. Jodoin, J., Demeule, M., Béliveay, R. (2002) Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim. Biophys. Acta 1542: 149-159
29. Johne, A., Brockmoller, J., Bauer, S., Maurer, A., Langheinrich, M., Roots, I. (1999) Pharmacokinetic interaction of digoxin with a herbal extract from St John's wort (Hypericum perforatum). Clin. Pharmacol. Ther. 66: 338-345
30. Johnston, A., Marsden, J. T., Hla, K. K., Henry, J. A., Holt, D. W. (1986) The effect of vehicle on the oral absorption of cyclosporin. Br. J. Clin. Pharmacol. 21: 331-333
31. Laroche, M., Choudri, S., Gallicano, K., Foster, B. (1998) Severe gastrointestinal toxicity with concomitant ingestion of ritonavir and garlic. Can. J. Infectious Dis. Supp. 9: 471
32. Lo, Y. L., Huang, J. D. (1999) Comparison of effects of natural or artificial rodent diet on etoposide absorption in rats. In Vivo 13: 51-55
33. Malhotra, S., Bailey, D. G., Paine, M. F., Watkins, P. B. (2001) Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins. Clin. Pharmacol. Ther. 69: 14-23
34. Middleton, E., Kandaswami, C., Theoharides, T. C. (2000) The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer. Pharmacol. Rev. 52: 673-751
35. Mitsunaga Y., Takanaga, H., Matsuo, H., Naito, M., Tsuruo, T., Ohtani, H., Sawada, Y. (2000) Effect of bioflavonoids on vincristine transport across blood-brain barrier. Eur. J. Pharmacol. 395: 193-201
36. Miyazawa, M., Okuno, Y., Fukuyama, M., Nakamura, S., Kosaka, H. (1999) Antimutagenic activity of polymethoxyflavonoids from Citrus aurantium. J. Agric. Food Chem. 47: 5239-5244
37. Motohashi, N., Kurihara, T., Wakabayashi, H., Yaji, M., Mucsi, I., Molnar, J., Maruyama, S., Sakagami, H., Nakashima, H., Tani, S., Shirataki, Y., Kawase, M. (2001) Biological activity of a fruit vegetable, "Anastasia green", a species of sweet pepper. In Vivo 15: 437-442
38. Ohnishi, A., Matsuo, H., Yamada, S., Takanaga, H., Morimoto, S., Shoyama, Y., Ohtani, H., Sawada, Y. (2000) Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4. Br. J. Pharmacol. 130: 1369-1377
39. Perloff, M. D., Von Moltke, L. L., Störmer, E., Shader, R. I., Greenblatt, D. J. (2001) Saint John's wort: An in vitro analysis of P-glycoprotein induction due to extended exposure. Br. J. Pharmacol. 134: 1601-1608
40. Piscitelli, S. C., Burnstein, A. H., Chiatt, D., Alfaro, R. M., Falloon, J. (2000) Indinavir concentrations and St John's Wort. Lancet 355: 547-548
41. Plouzek, C. A., Ciolino, H. P., Clarke, R., Yeh, G. C. (1999) Inhibition of P-glycoprotein activity and reversal of multidrug resistance in vitro by rosemary extract. Eur. J. Cancer 35: 1541-1545
42. Reppas, C., Eleftheriou, G., Macheras, P. Symillides, M., Dressman, J. B. (1998) Effects of elevated viscosity in the upper gastrointestinal tract on drug absorption in dogs. Eur. J. Pharm. Sci. 6: 131-139
43. Ruschitzka, F., Meijer, P. J., Turina, M., Luscher, T. F., Noll, G. (2000) Acute heart transplant rejection due to Saint John's wort. Lancet 355: 548-549
44. Scalbert, A., Williamson, G. (2000) Dietary intake and bioavailability of polyphenols. J. Nutr. 130: 2073S-2085S.
45. Scambia, G., Ranelletti, F. O., Panici, P. B., De Vincenzo, R., Bonanno, G., Ferrandina, G., Piantelli, M., Bussa, S., Rumi, C., Cianfriglia, M. (1994) Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-gp as a possible target. Cancer Chemother. Pharmacol. 34: 459-464
46. Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A., Van Deemter, L., Smit, J. J., Van Der Valk, M. A., Voordouw, A. C., Spits, H., Van Tellingen, O., Zijlmans, J. M., Fibbe, W. E., Borst, P. (1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug transporting) P-glycoproteins. Proc. Natl Acad. Sci. USA 94: 4028-4033
47. Schuetz, E. G., Umbenhauer, D. R., Yasuda, K., Brimer, C., Nguyen, L., Relling, M. V., Schuetz, J. D., Schinkel, A. H. (2000) Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes. Mol. Pharmacol. 57: 188-197
48. Shapiro, A. B., Ling, V. (1997) Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem. Pharmacol. 53: 587-596
49. Singh, B. N. (1999) Effects of food on clinical pharmacokinetics. Clin. Pharmacokinet. 37: 213-255
50. Soldner, A., Christiaens, U., Susanto, M., Wacher, V. J., Silverman, J. A., Benet, L. Z. (1999) Grapefruit juice activates P-glycoprotein-mediated drug transport. Pharm. Res. 16: 478-485
51. Spahn-Langguth, H., Langguth, P. (2001) Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur. J. Pharm. Sci. 12: 361-367
52. Spahn-Langguth, H., Baktir, G., Radschuweit, A., Okyar, A., Terhaag, B., Ader, P., Hanafy, A., Langguth, P. (1998) P-glycoprotein transporters in the intestinal tract: Evaluation of the potential in vivo relevance of in vitro data employing talinolol as a model compound. Int. J. Clin. Pharmacol. Ther. 36: 16-24
53. Takanaga, H., Ohnishi, A., Matsuo, H., Sawada, Y. (1998) Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in Caco-2 cells. Biol. Pharm. Bull. 21: 1062-1066
54. Takanaga, H., Ohnishi, A., Yamada, S., Matsuo, H., Morimoto, S., Shoyama, Y., Ohtani, H., Sawada, Y. (2000) Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P540 3A4. J. Pharmacol. Exp. Ther. 293: 230-236
55. Thiebaut, F., Tsuruo, T, Hamada, H., Gottesman, M. M., Pastan, I., Willingham, M. C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl Acad. Sci. USA 84: 7735-7738
56. Tian, R., Koyabu, N., Takanaga, H., Matsuo, H., Ohtani, H., Sawada, Y. (2002) Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm. Res. 19: 802-809
57. Tseng, E., Liang, W., Wallen, C., Morris, M. E. (2001) Effect of flavonoids on P-gp mediated transport in a human breast cancer cell line. AAPS PharmSci 3: S2081
58. Turton-Weeks, S. M., Barone, G. W., Gurley, B. J., Ketel, B. L., Lightfoot, M. L., Abul-Ezz, S. R. (2001) St. John's wort: A hidden risk for transplant patients. Prog. Transplant. 11: 116-120
59. Van Gelder, J., Deferme, S., Naesens, L., De Clercq, E., Van Den Mooter, G., Kinget, R., Augustijns, P. (2002) Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures. Drug Metab. Dispos. 30: 924-930
60. Vine, D. F., Charman, S. A., Gibson, P. R., Sinclair, A. J., Porter, C. J. (2002) Effect of dietary fatty acids on the intestinal permeability of marker drug compounds in excised rat jejunum. J. Pharm. Pharmacol. 54: 809-819
61. Wacher, V. J., Wong, S., Wong, H. T. (2001) Peppemint oil enhances cyclosporin oral bioavailability in rats: Comparison with D-a-tocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole. J. Pharm. Sci. 91: 77-90
62. Wagner, D., Spahn-Langguth, H., Hanafy, A., Koggel, A., Langguth, P. (2001) Intestinal drug efflux: Formulation and food effects. Adv. Drug Deliv. Rev. 50: S13-S31
63. Wang, E., Casciano, C. N., Clement, R. P., Johnson, W. W. (2001a) Inhibition of P-glycoprotein transport function by grapefruit juice psoralen. Pharm. Res. 18: 432-438
64. Wang, Z., Gorski, C., Hamman, M. A., Huang, S.-M., Lesko, L. J., Hall, S. D. (2001b) The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clin. Pharmacol. Ther. 70: 317-326
65. Welling, P. G. (1996) Effects of food on drug absorption. Annu Rev. Nutr. 16: 383-415
66. Yumoto, R., Murakami, T., Nakamoto, Y., Hasegawa, R., Nagai, J., Takano, M. (1999) Transport of Rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P450 3A-related compounds. J. Pharmacol. Exp. Ther. 289: 149-155